IDBI Healthcare Fund Direct Growth
IDBI Healthcare Fund Direct Growth

IDBI Healthcare Fund Direct Growth

Equity
Direct
Very High Risk
Sector - Healthcare

NAV: ₹ 19.78 as on 26-10-2021

Fund Overview

Expense ratio
Expense ratio
1.24%
Benchmark
Benchmark
S&P BSE Healthcare PR
AUM
AUM
₹80 Cr
Inception Date
Inception Date
28 February, 2019
Min Lumpsum/SIP
Min Lumpsum/SIP
₹5000/₹1500
Exit Load
Exit Load
1%
Lock In
Lock In
No Lock-in
TurnOver
TurnOver
1876.85%

Fund Distribution

  • Equity 97.4%
  • Debt & Cash 2.6%
Size breakup
Large cap
75.22%
Mid cap
21.7%
Small cap
3.09%
Sector Allocation
Health92.5%
Basic Materials5.1%
Financial Services2.3%

Top Holdings

  • All
  • Equity
  • Debt & Cash
Total Holdings32
Equity Holdings30
Debt Holdings2
Sun Pharmaceuticals Industries Ltd
Sun Pharmaceuticals Industries Ltd
13.2%
Divi's Laboratories Ltd
Divi's Laboratories Ltd
10.6%
Dr Reddy's Laboratories Ltd
Dr Reddy's Laboratories Ltd
9.2%
Cipla Ltd
Cipla Ltd
8.2%
Apollo Hospitals Enterprise Ltd
Apollo Hospitals Enterprise Ltd
5%
Aurobindo Pharma Ltd
Aurobindo Pharma Ltd
4.4%
Lupin Ltd
Lupin Ltd
3.8%
Ipca Laboratories Ltd
Ipca Laboratories Ltd
3.7%

Fund Highlights

Fund Manager

Fund Manager

Alok Ranjan
About the fund

About the fund

This fund has delivered an average annual returns of 29.25% since inception which is less than its category average return of 31.29%
Fund Allocations

Fund Allocations

This fund has an allocation of 97.4% in Equity, 0% in Debt and 2.6% in Cash related instruments
AUM size ₹80 Cr

AUM size ₹80 Cr

This fund has AUM of ₹80 Cr which is less than its category average of ₹ 1628 Cr
Expense Ratio 1.24%

Expense Ratio 1.24%

This fund has an expense ratio of 1.24% which is less than its category average expense ratio of 1.57%

AMC details

Fund House
IDBI Asset Management Limited
Email
contactus@idbimutual.co.in
Phone
+912266442800
Address
IDBI Asset Management Ltd.,5th floor, Mafatlal Centre,,Nariman Point,
We are a SEBI registered investement advisor